Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
The comment period closed Aug 17, 2026.
This proposed rule would codify the Medicare Drug Price Negotiation Program ("Negotiation Program") and would establish certain new policies for the Negotiation Program and the Medicare Prescription Drug Benefit Program as required by the Inflation Reduction Act of 2022. This proposed rule would also propose a modification to the fixed combination drug policy.
Summary from the Federal Register.
Read the rule
Full history
- Jun 16, 2026
Rule published
Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
Health and Human Services Department
About this record
- Source
From the Federal Register. This record was last updated Sep 24, 2026. About our data
- What it is
A rule from Health and Human Services Department. Agora lists the comment window as the Federal Register gives it.
- Dates
Dates are in Eastern time.
This record shows the rule as proposed. A final rule, if any, is a separate Federal Register document.
- This page
Agora assembled this page from the Federal Register. The title and summary are the agency's, as the Federal Register prints them.